BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 25321320)

  • 21. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
    Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
    Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying target audiences: who are the guidelines for? : article 1 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Yawn BP; Akl EA; Qaseem A; Black P; Campos-Outcalt D;
    Proc Am Thorac Soc; 2012 Dec; 9(5):219-24. PubMed ID: 23256162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.
    Howcroft M; Walters EH; Wood-Baker R; Walters JA
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD005074. PubMed ID: 27990628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.
    O'Donnell DE; Aaron S; Bourbeau J; Hernandez P; Marciniuk DD; Balter M; Ford G; Gervais A; Goldstein R; Hodder R; Kaplan A; Keenan S; Lacasse Y; Maltais F; Road J; Rocker G; Sin D; Sinuff T; Voduc N
    Can Respir J; 2007 Sep; 14 Suppl B(Suppl B):5B-32B. PubMed ID: 17885691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary issues in the care of patients with chronic obstructive pulmonary disease.
    Urbano FL; Pascual RM
    J Manag Care Pharm; 2005 Jun; 11(5 Suppl A):S2-13; quiz S14-6. PubMed ID: 15934804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement.
    Kim V; Aaron SD
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30237306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How should we manage an acute exacerbation of COPD?
    Holten KB
    J Fam Pract; 2003 Oct; 52(10):780-2. PubMed ID: 14529602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010010. PubMed ID: 28626902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overuse of long-acting β
    Brunton SA; Hogarth DK
    Postgrad Med; 2023 Nov; 135(8):784-802. PubMed ID: 38032494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]   [Full Text] [Related]  

  • 37. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003.
    O'Donnell DE; Aaron S; Bourbeau J; Hernandez P; Marciniuk D; Balter M; Ford G; Gervais A; Goldstein R; Hodder R; Maltais F; Road J;
    Can Respir J; 2003; 10 Suppl A():11A-65A. PubMed ID: 12861361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline.
    Mammen MJ; Pai V; Aaron SD; Nici L; Alhazzani W; Alexander PE
    Ann Am Thorac Soc; 2020 Sep; 17(9):1133-1143. PubMed ID: 32530702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.